How much revenue does ZIM make?

ZIM reported $0 in revenue for fiscal year 2021. In Q2 2022 revenue was $0.

What companies are similar to ZIM?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include RegeneRx Biopharmaceuticals, Inc. (RGRX), Juva Life Inc. (JUVAF), Hempfusion Wellness Inc. (CBDHF), Pure Global Cannabis Inc. (PRCNF).

ZIM Corporation (ZIMCF) Stock

About ZIM Corporation

ZIM Corporation operates in the biomedical and emerging technology companies. It focuses on developing intellectual property, and research and development in the areas of new synthetic drugs and Immunotherapies. The company also offers spherical metal powders for additive manufacturing; and develops novel biomaterial for regenerative medicine. ZIM Corporation was founded in 1997 and is headquarter...

At a glance

ZIM reported revenue of $0 for fiscal year 2021, and net income of -$76,568. In Q2 2022 (the quarter ended September 30, 2021) revenue was $0.

Figures from company filings; latest fiscal year ended March 31, 2021.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.